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A deep dermal suppurative granuloma. HE. ×100. occur in Central and South America. Eumycotic mycetomas are caused by phaeohyphomycetes ( Exophiala spp., Madurella spp.) or hialohyphomycetes ( Acremonium spp., Aspergillus spp., Fusarium spp., Pseudallescheria spp.) [4] . Etiological agents penetrate the skin through breaks caused by thorns, shrubs, and wood splinters: mycetoma is considered an occupational disease in farmers and lumberjacks. Latency time may be very long (months, years). Mycetomas are characterized clinically by the slow appearance of mildly inflammatory papules, nodules, and plaques. With time, abscesses, fistulae, and ulcers appear, with a serouspurulent discharge containing "grains" (i.e., colonies of the involved species). White or yellow grains are typical of A. madurae , A. nidulans [4] , and Pseudallescheria boydii ; red grains are typical of Actinomadura pelletieri ; black grains of Aspergillus terreus , Exophiala jeanselmei , and M. mycetomatis. Superinfections by Staphylococcus aureus, gram-negative bacteria, and anaerobes are frequent. Mycetomas are usually located on the legs, ankles, and feet ("Madura foot"); the buttocks and thighs may be also involved. The involvement of muscles, aponeuroses, ligaments, tendons, joints, and bones is rather common. Local symptoms are usually mild, except for difficulty walking. The clinical course is chronic-relapsing [1] . The diagnosis of mycetoma is based on medical history, clinical picture, histopathological examination, mycological and bacteriological cultures, and PCR. The use of X-rays, ultrasonography, and computed tomography scan is necessary in order to evaluate the involvement of deep tissues. The therapy of eumycotic mycetomas is difficult and very long [5] . Several systemic antimycotics, such as fluconazole, itraconazole, ketoconazole, posaconazole, voriconazole, and terbinafine, have been used. The association itraconazole-terbinafine seems to be more effective than itraconazole alone and terbinafine alone. Isavuconazole is a promising drug. Surgery is necessary in most of the patients.
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